Improved predictive value of biomarkers in HF makes earlier diagnosis and better management possible

March 30, 2009

With an ever ageing population and more people surviving a heart attack, heart failure is now the world's most prevalent chronic cardiovascular disease. Yet despite improvements in its diagnosis and management, heart failure remains a stubbornly incurable condition with a poor prognosis, largely amenable to little more than palliative therapy.

Heart failure describes a syndrome of symptoms without a single diagnostic test. However, the discovery and application of markers of disease (biomarkers) have improved risk stratification in heart failure and made earlier detection possible. Now, reports in the April issue of the European Journal of Heart Failure suggest two more efficient applications of biomarkers, and with them the promise of even earlier diagnosis and improved treatment.

1. According to results from a study in Hull, UK, repeat measurement of the well established biomarker N-terminal pro-B-type natriuretic peptide (NT-proBNP) once treatment has been optimised provides stronger prognostic information than either the baseline value, the change in NT-proBNP, or other conventional methods of assessment. (1)

The finding emerged from a study of 354 patients with chronic heart failure treated in a community-based heart failure programme. Measurement of (NT-proBNP) was performed at baseline and, in those surviving (318), once again between the fourth and sixth month of follow-up. During the study follow-up period (a median of 39 months) 125 patients died, and analysis showed that follow-up NT-proBNP measurement proved a better predictor of death than either baseline NT-proBNP or change in NT-proBNP. Indeed, say the authors, NT-proBNP "was consistently the strongest independent prognostic marker at predicting death or unplanned cardiovascular hospitalisations after baseline or follow-up assessment".

First author Dr Milos Kubanek from Castle Hill Hospital, Hull, UK, added: "NT-proBNP monitoring will enable the identification of patients who are not responding well to treatment or help flag those patients needing more aggressive management and monitoring. We found NT-proBNP to be a much stronger predictor of mortality and CV-hospitalisation than echocardiographic measurements of, for example, ejection fraction, and therefore repeat NT-proBNP measurement may enable a reduction in the number of repeat echocardiograms.

"We suggest that the main role of conventional echocardiography should be to diagnose and differentiate the principal causes of heart failure, with subsequent NT-proBNP monitoring used to identify worsening disease and trigger further echocardiographic assessment. Given the relatively high cost of echocardiography compared to NT-proBNP, such a policy is likely to be cost effective."

2. A study from Sweden suggests the combined application of two independently established biomarkers gives better prognostic information about the risk of cardiovascular mortality in heart failure patients than just one biomarker.(2) This was a study of 464 elderly patients with the symptoms of heart failure followed up over a ten-year period Linkoping University Hospital. Throughout that time serum measurements of the biomarker cystatin C (a marker of renal function) were taken, with results showing that those with levels within the highest quartile had almost three times the risk of cardiovascular death than those with levels in the first, second, or third quartiles.

However, when these measurements were combined with measurements of NT-proBNP, the mortality risk assessment was even more emphatic. For example, if those with high concentrations of cystatin C also had a plasma concentration of NT-proBNP within the highest quartile, the risk of death increased to more than 13 times over ten years of follow-up and almost 17 times after five years of follow-up.

The study's first author, Dr Urban Alehagen from the Heart Center of Linkoping University Hospital, Linkoping, Sweden, said: "Because the majority of patients with heart failure are elderly and often affected by other organ symptoms, including renal impairment, it is important to identify those at high risk, both for the provision of optimal treatment and the most effective use of health resources. The use of a single blood test and the analysis of two biomarkers is one way of identifying those patients where health resources are best focused. More and more clinicians are using information from natriuretic peptides. However, it is now possible to expand the use of these biomarkers in clinical practice, and our study proposes one such potent combination."

The use of biomarkers for identifying those at risk of cardiovascular mortality is now central to the management of patients with heart failure. Research now aims to find new, more sensitive markers and more efficient use of existing markers. The ultimate aim, as this issue of the European Journal of Heart Failure suggests, is to make earlier and more accurate diagnosis possible, and thereby improve treatment and survival.

Commenting on the implications of the findings, Professor Karl Swedberg, Editor-in-Chief of the European Journal of Heart Failure, said: "A combination of biomarkers to improve diagnosis and prognosis - as suggested by Alehagen and colleagues - now seems to be the basis of optimal management of patients with heart failure."

European Society of Cardiology

---

---

	Success with Heart Failure (mass mkt ed): Help and Hope for Those with Congestive Heart Failure by Marc Silver (Author) Up-to-date information on available and forthcoming medical and surgical treatments. How attitude and emotion affect heart failure-and what you can do to stay positive. Tips for adopting a heart-healthy diet and lifestyle. Ways to forge a positive working relationship with your doctor or cardiologist.
	Living Well with Heart Failure, the Misnamed, Misunderstood Condition by Edward K. Kasper (Author), Mary Knudson (Author) Heart failure—the expression alone is scary. The idea that the blood-pumping organ in our chest can struggle, stutter, or suddenly stop is deeply disconcerting. But for those who get the diagnosis, the future is not necessarily bleak. With the right treatments and a healthy lifestyle that includes exercise and good nutrition, many people with heart failure can improve their condition and live well. Heart failure expert Edward K. Kasper, M.D., teams with journalist—and survivor—Mary Knudson to give readers an honest account of this misunderstood condition. The authors explain the complex science of heart failure and look critically at the care available. Living Well with Heart Failure, the Misnamed, Misunderstood Condition will help readers understand:• The causes of the...
	Heart Failure: A Companion to Braunwald's Heart Disease: Expert Consult - Online and Print, 2e (Expert Consult Title: Online + Print) by Douglas L. Mann MD FACC (Author) Dr. Douglas L. Mann, one of the foremost experts in the field, presents the 2nd Edition of Heart Failure: A Companion to Braunwald's Heart Disease. This completely reworked edition covers the scientific and clinical guidance you need to effectively manage your patients and captures the dramatic advances made in the field over the last five years. Now in full color and with convenient online access, this edition features eleven new chapters, including advanced cardiac imaging techniques, use of biomarkers, cell-based therapies and tissue engineering, device therapies, and much more. Includes access to the complete contents online, fully searchable, enabling you to consult it rapidly from any computer with an Internet connection. Incorporates an enhanced emphasis on surgical outcomes to...
	The Cleveland Clinic Guide to Heart Failure (Cleveland Clinic Guides) by Randall Starling (Author) Expert medical advice from the #1 heart center in America for 14 years in a rowFor the 5 million people with heart failure, there’s new reason for hope: recent medical advances have revolutionized how this condition is managed.In The Cleveland Clinic Guide to Heart Failure, Dr. Randall Starling, one of the foremost authorities on heart health, provides authoritative advice to help people survive heart failure and enjoy a good quality of life. This comprehensive resource gives readers the cutting-edge medical guidance Dr. Starling offers his patients, including: Insight into what causes heart failure; The latest breakthrough studies – and what those discoveries mean for the future of this disease; Reliable guidance on diagnostic tests and treatment options; Personal...
	Management of Heart Failure by Barry Greenberg (Editor), Denise Barnard (Editor), Sanjiv Narayan (Editor), John Teerlink (Editor) This volume presents a fresh international perspective on current approaches to treating heart failure. An accessible reference for hospital-based specialists, the book provides an update on recent advances in therapeutics and pharmacology, as well as ongoing trials. Four major sections concentrate on a review of screening, assessment and diagnosis; an update on drug treatments; an update on device therapy; and a description of best practice recommendations for managing clinically challenging cases
	Oxford Textbook of Heart Failure (Oxford Textbooks in Cardiology) by Theresa A. McDonagh (Author), Roy S. Gardner (Author), Andrew L. Clark (Author), Henry Dargie (Author) Although the incidence of coronary heart disease is falling, its major complication, heart failure, is increasing in frequency. All health care practitioners will encounter patients with heart failure, presenting either acutely or in need of chronic heart failure management. However with recent advances in medical therapy, the prognosis of the condition has improved dramatically so that whereas once heart failure was a pre-terminal diagnosis, now for many it is treatable. Taking the reader from an understanding of the basic mechanisms of heart failure through to an appreciation of the complexities of heart failure management and the remarkable improvements possible with good treatment, this definitive textbook is written by internationally renowned leaders in their field and...
	Heart Failure: Pathophysiology, Molecular Biology, and Clinical Management (HEART FAILURE: PATHOPHYSIOLOGY, MOLEC BIOL & CLIN MGT) by Arnold M. Katz MD (Author), Marvin A. Konstam (Author) This Second Edition of Dr. Katz's highly acclaimed text has been thoroughly revised to incorporate the latest advances in the study and treatment of heart failure. The book explains the pathophysiology, molecular mechanisms, clinical manifestations, and therapy of heart failure in an integrated, reader-friendly manner that is accessible to both clinicians and basic scientists. More than 100 illustrations, most created for this book by the authors, complement the text. This edition has been completely reorganized. Chapters describe the hemodynamic basis for the clinical manifestations of heart failure; the neurohumoral responses in heart failure and key signaling pathways that mediate functional responses; the proliferative responses in failing hearts; the cellular and molecular...
	Heart Failure in Clinical Practice by Michael Y. Henein (Editor) Heart Failure in Clinical Practice provides a toolkit for clinicians to guide them in the diagnosis and treatment of patients with suspected heart failure. Algorithms and flow diagrams are included to give the reader an illustrated snapshot of the decisions involved in the management of these patients.
	Mechanical Circulatory Support: A Companion to Braunwald's Heart Disease: Expert Consult: Online and Print, 1e by Robert L. Kormos MD FRCS(C) FACS FAHA (Author), Leslie W. Miller MD (Author) Mechanical Circulatory Support, by Drs. Robert L. Kormos and Leslie W. Miller, provides the clinically relevant information you need to effectively use this therapy to treat and manage end-stage cardiovascular disease. In this Companion to Braunwald's Heart Disease, the world's most prominent experts in mechanical circulatory support (MCS) cover basic science, device construction, clinical applications, socioeconomic implications, future directions, and more. Stay on top of hot topics - including innovative devices like continuous flow pumps, next-generation centrifugal pumps, and total artificial hearts; MCS for pediatric and congenital heart disease; cellular, molecular, genomic, and functional changes that occur in the failing heart in response to MCS; and Interagency Registry of...
	Heart Failure Pocketcard Set by Anita D. Szady (Author), Anthony A. Bavry (Author) The Heart Failure pocketcard Set contains a collection of important information on the pathophysiology, diagnosis and management of heart failure including: * Neurohormonal mechanisms of heart failure and common causes of nonischemic cardio myopathy * Heart failure staging information including stage-specific treatment guidelines * The correct assessment and treatment of acute decompensate heart failure * A PRIDE score- and BNP level-based algorithm for the management and triage of patients with suspected acute congestive heart failure * Instructions on the initial evaluation of patients with heart failure including history and physical and laboratory data information * AHA/ACC/HRS guidelines on cardiac defibrillation and resynchronization therapy * Pharmacologic therapy...